Article
Synergistic effect of deoxynucleosides and AAV gene therapy for thymidine kinase 2 deficiency
2020-10-08
Abstract excerpt
Autosomal recessive thymidine kinase 2 ( TK2 ) mutations causes TK2 deficiency, which typically manifests as a progressive and fatal mitochondrial myopathy in infants and children. Treatment with deoxycytidine and thymidine ameliorates mitochondrial defects and extends lifespan of Tk2 knock-in mouse (TK2 −/− ); however, efficacy is limited by age- and tissue-dependent expression of the cytosolic enzymes Tk1 and...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 32b57e8f-2d04-58c1-9787-728bb5dacfd9
- DOI
- 10.1101/2020.10.08.330969
